Gayatri BioOrganics Ltd
BSE: GAYATRIBI · Commodity Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Gayatri BioOrganics Ltd's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Gayatri BioOrganics Limited is an Indian manufacturer specialising in the processing of maize into starch and starch derivatives. Its product portfolio includes maize starch, liquid glucose, sorbitol, and gluten, which serve as critical raw materials for the pharmaceutical, food and beverage, textile, and paper industries.
Business Model
The company operates a large-scale processing facility in Telangana, leveraging proximity to maize-growing regions to optimise supply chain costs. It generates revenue by converting agricultural commodities into value-added industrial chemical products for both domestic and export markets.
Growth Outlook
Growth is driven by the increasing demand for starch derivatives across diverse industrial sectors and the company's strategic focus on maintaining production capacity in South India. The firm aims to capitalise on its established supply chain to serve expanding domestic and international markets.
Key Risks
- Raw Material Price Volatility. Fluctuations in maize prices directly impact production costs and profit margins due to the company's reliance on agricultural inputs.
- Regulatory and Environmental Compliance. As a chemical processing entity, the company is subject to stringent environmental regulations regarding waste management and industrial emissions.
- Supply Chain Dependency. The company's operational efficiency is highly dependent on the seasonal availability and quality of maize crops in the Telangana region.
- Market Competition. The starch and derivatives market is highly competitive, with pricing pressure from both domestic players and international imports.
Start your research today
Unlock AI insights, financials, peers and live data on Gayatri BioOrganics Ltd and 5,000+ companies — free.
Key Metrics
NET PROFIT
₹1 Cr
TTM · standalone
EPS
₹0.09
TTM · standalone
RETURN ON EQUITY
3.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
-5.9%
TTM · standalone
P/E
76.7x
Q4 FY26 · standalone
EV/EBITDA
104.0x
Q4 FY26 · standalone
DEBT TO EQUITY
1.0x
Q4 FY26 · standalone
Peers · Commodity Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Gayatri BioOrganics LtdGAYATRIBI | ₹58 Cr | 82.22 | 64.80 | — | -59.3% | 3.1% | -5.9% | -38.3% |
Blue Pearl Agriventures LimitedBPAGRI | ₹525 Cr | — | — | — | 2.7% | — | — | -92.2% |
Primo ChemicalsPRIMO | ₹517 Cr | 32.82 | 7.31 | -2.7% | 15.8% | 4.0% | 7.1% | -16.6% |
POCL EnterprisesPOEL | ₹460 Cr | 10.53 | 7.57 | — | 5.3% | 21.3% | 33.7% | -37.2% |
Mangalam OrganicMANORG | ₹437 Cr | 21.41 | 8.88 | 17.3% | 13.6% | 6.8% | 15.9% | -7.2% |
Lords Chloro Alkali LimitedLORDSCHLO | ₹402 Cr | 11.52 | 7.91 | 29.8% | 17.3% | 15.6% | 14.1% | -18.7% |
As of Q4 FY26
Financials
Gayatri BioOrganics Ltd
BSE: GAYATRIBI · Commodity Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Gayatri BioOrganics Ltd's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Gayatri BioOrganics Limited is an Indian manufacturer specialising in the processing of maize into starch and starch derivatives. Its product portfolio includes maize starch, liquid glucose, sorbitol, and gluten, which serve as critical raw materials for the pharmaceutical, food and beverage, textile, and paper industries.
Business Model
The company operates a large-scale processing facility in Telangana, leveraging proximity to maize-growing regions to optimise supply chain costs. It generates revenue by converting agricultural commodities into value-added industrial chemical products for both domestic and export markets.
Growth Outlook
Growth is driven by the increasing demand for starch derivatives across diverse industrial sectors and the company's strategic focus on maintaining production capacity in South India. The firm aims to capitalise on its established supply chain to serve expanding domestic and international markets.
Key Risks
- Raw Material Price Volatility. Fluctuations in maize prices directly impact production costs and profit margins due to the company's reliance on agricultural inputs.
- Regulatory and Environmental Compliance. As a chemical processing entity, the company is subject to stringent environmental regulations regarding waste management and industrial emissions.
- Supply Chain Dependency. The company's operational efficiency is highly dependent on the seasonal availability and quality of maize crops in the Telangana region.
- Market Competition. The starch and derivatives market is highly competitive, with pricing pressure from both domestic players and international imports.
Start your research today
Unlock AI insights, financials, peers and live data on Gayatri BioOrganics Ltd and 5,000+ companies — free.
Key Metrics
NET PROFIT
₹1 Cr
TTM · standalone
EPS
₹0.09
TTM · standalone
RETURN ON EQUITY
3.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
-5.9%
TTM · standalone
P/E
76.7x
Q4 FY26 · standalone
EV/EBITDA
104.0x
Q4 FY26 · standalone
DEBT TO EQUITY
1.0x
Q4 FY26 · standalone
Peers · Commodity Chemicals
As of Q4 FY26